PharmAla Biotech Holdings Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MDXXF for the last quarter is 66.57 k USD, and it's 88.00% lower compared to the previous quarter. The net income of Q2 24 is -163.87 k USD.